The PI3KÎ´ inhibitor idelalisib suppresses liver and lung cellular respiration.

Hammadi, Suleiman Al; Almarzooqi, Saeeda; Abdul-Kader, Hidaya Mohammed; Saraswathiamma, Dhanya; Souid, Abdul-Kader

Hammadi, Suleiman Al; Almarzooqi, Saeeda; Abdul-Kader, Hidaya Mohammed; Saraswathiamma, Dhanya; Souid, Abdul-Kader.

Afiliação

Hammadi SA; Department of Pediatrics, UAE University Al-Ain, Abu Dhabi, United Arab Emirates.
Almarzooqi S; Department of Pathology, UAE University Al-Ain, Abu Dhabi, United Arab Emirates.
Abdul-Kader HM; Department of Medicine, UAE University Al-Ain, Abu Dhabi, United Arab Emirates.
Saraswathiamma D; Department of Pathology, UAE University Al-Ain, Abu Dhabi, United Arab Emirates.
Souid AK; Department of Pediatrics, UAE University Al-Ain, Abu Dhabi, United Arab Emirates.

Int J Physiol Pathophysiol Pharmacol ; 7(3): 115-25, 2015.

Article em En | MEDLINE | ID: mdl-26823960

Palavras-chave

Cellular bioenergetics; PI3K delta; PI3K inhibitors; cellular respiration; idelalisib; liver toxicity; lung toxicity; mitochondrial function; oxidative phosphorylation

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Int J Physiol Pathophysiol Pharmacol Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Emirados Árabes Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google